NEW HAVEN, Conn--Lee Philip Schacter, PhD, MD, has been named
associate director for clinical trials for the Yale Cancer Center.
In that role, he will oversee the clinical research projects on
experimental cancer treatment taking place at the Center. Dr.
Schacter comes to Yale from Bristol-Myers Squibb, where he was
a director of the clinical cancer research program.
His top priority in his new position will be to further development
of the Center's new clinical research program. "We have most
of the people in place," he said, referring to the Center's
corps of research scientists and physicians. "And we have
promising experimental treatment programs underway. That combination
makes this a place people look to for progressive cancer therapy."
Dr. Schacter will also be instrumental in building a network for
community-based clinical research. The effort will involve extending
research projects to community hospitals throughout Connecticut
as well as physicians' offices.